亚膝扣带回规范连接对TMS治疗位点抗抑郁反应的预测价值:一项前瞻性多中心队列研究
主要分析未发现TMS位点与亚膝扣带回(SGC)的规范连接与抗抑郁反应相关(r=0.1,p=0.39)。事后分析加入临床协变量后关联显著(r=-0.27,p=0.014),基线焦虑和共病精神障碍解释反应方差最多。
要点
- TMS位点与SGC规范连接与抗抑郁反应无显著相关(r=0.1,p=0.39)。
- 加入临床协变量后关联显著(r=-0.27,p=0.014)。
- 基线焦虑和共病精神障碍解释反应方差最多。
核心结论
- 在多样本临床人群中,TMS位点与SGC的规范连接未能显著预测抗抑郁反应。
- 基于规范连接组推导的「抗亚膝扣带回」靶点可能对高基线焦虑或精神共病患者次优。
研究设计与样本
- 患者接受3-8周每日左侧背外侧前额叶rTMS,采用头皮定位作为标准临床护理的一部分。
- 刺激位点通过MRI神经导航在多天记录。
主要发现
- 主要结局:BDI-II评分变化与个体TMS位点至SGC连接的相关性无统计学意义(r=0.1,p=0.39)。
- TMS位点定位一致性良好,个体内方差小于个体间方差(p<0.0001)。
- 事后分析加入临床协变量后关联显著(r=-0.27,p=0.014)。
- 基线焦虑(p<0.0001)和共病精神障碍(p<0.001)解释反应方差最多。
关键数值与推荐
- 主要分析未发现TMS位点与SGC规范连接和抗抑郁反应相关(r=0.1,p=0.39)。
- 事后分析加入临床协变量后关联显著(r=-0.27,p=0.014)。
- 基线焦虑(p<0.0001)和共病精神障碍(p<0.001)解释反应方差最多。
临床怎么用
- 基于规范连接组的「抗亚膝扣带回」靶点可能在临床实践中对高基线焦虑或精神共病患者效果不佳。
- 临床选择TMS靶点时需考虑患者基线焦虑和共病精神障碍。
局限性
- 主要分析未发现显著关联,仅事后分析显著。
- 规范连接数据来自1000名健康个体,可能不完全代表患者群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Small single-site studies found that transcranial magnetic stimulation (TMS) targets with better antidepressant response were more negatively functionally connected to the subgenual cingulate cortex (SGC). These led to "anti-subgenual" TMS targeting in recent clinical trials. We conducted a larger prospective multi-site observational study to test the robustness of this observation in more diverse clinical populations. Sixty-six treatment-seeking individuals with major depressive disorder (MDD) received 3-8 weeks of daily rTMS to the left dorsolateral prefrontal cortex using scalp-based targeting as part of standard clinical care. Stimulation sites were recorded with MRI neuronavigation on multiple days. Our primary outcome was the correlation between change in Beck Depression Inventory (BDI-II) score and connectivity of each individual's TMS site to the SGC, computed using resting-state functional connectivity data from 1000 healthy individuals. Secondary (post hoc) analyses incorporated additional clinical covariates. No relationship was found between antidepressant response and normative connectivity of TMS site to SGC (r = 0.1, p = 0.39). This was not due to inconsistency in the location of the TMS sites, which showed smaller within- than between-individual variance (p < 0.0001). Post hoc analyses showed significant associations when adding clinical covariates (r = -0.27, p = 0.014). Baseline anxiety (p < 0.0001) and comorbid psychiatric conditions (p < 0.001) accounted for the most variance in response. Atlas-based connectivity of TMS site to the SGC accounted for minimal variance in antidepressant response in this diverse sample. The "anti-subgenual" target derived based on normative connectome may be suboptimal for MDD patients with high baseline anxiety or psychiatric comorbidities. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03276793.
引用
- Khosravani S, Palm ST, Drew W, et al. Predictive value of subgenual cingulate normative connectivity to TMS treatment site for antidepressant response in routine clinical practice: a prospective, multisite cohort study. Mol Psychiatry. 2025. PMID: 40847007. doi:10.1038/s41380-025-03153-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。